← Back to Bmo Capital

David Lebowitz Score: 43

Analyst at BMO Capital
Avg Return (Buy)
? How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).

Note: Sell ratings are ignored here to focus on investment potential.
+33.8%
1 Year Cap
Win Rate
? How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
80%
12 W / 3 L
Target Met
? How often was the target reached?
Hits vs. Total.
69%
9 W / 4 L
Precision Hit
? How often precise (±3%)?
Hits vs. Total.
15%
2 W / 11 L
Bullseye Hit
? How often perfect (±1%)?
Hits vs. Total.
8%
1 W / 12 L
High Conviction
? The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
82%
9 W / 2 L
Long Wins
? Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
80%
12 W / 3 L
Short Wins
? Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L

Coverage & Price Targets

Date Stock Signal Target Start Price Best Price (1Y) Accuracy Current Price
Aug 18, 2026
Akoustis Technologies Inc AKTS
BUY $37.00
Est. +48%
$25.00 $27.66
Pending
$26.65 +6.6%
Aug 18, 2026
Biomarin Pharmaceutical Inc. - Registered Shares BMRN
BUY $98.00
Est. +46%
$66.99 $68.29
Pending
$66.43 -0.8%
Akoustis Technologies Inc
AKTS
Aug 18, 2026
Signal & Target
BUY $37.00
Start Price $25.00
Best Price (1Y)
$27.66
Current Price $26.65
Return +6.6%
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
Aug 18, 2026
Signal & Target
BUY $98.00
Start Price $66.99
Best Price (1Y)
$68.29
Current Price $66.43
Return -0.8%